The first targeted cancer drug in pill form produced in Thailand, "Imcranib 100", from the genius and wisdom of Her Royal Highness Princess Maha Chakri Sirindhorn.
On July 5, 2025, Chulabhorn Hospital announced that Professor Dr. Her Royal Highness Princess Chulabhorn has carefully set a policy for research and production of cancer drugs. She has given importance to patient care in all dimensions, including the development of highly effective targeted cancer drugs that inhibit the activity of the enzyme tyrosine kinase (Tyrosine Kinase Inhibitors ) for the treatment of various types of cancer, with good treatment results and few side effects, and is accepted by oncology specialists. The first targeted cancer drug produced in Thailand is IMCRANIB 100 / IMCRANIB 100, which consists of the active ingredient IMATINIB 100 mg. It has been registered with the Food and Drug Administration (FDA), Ministry of Public Health, on May 20, 2025, and is ready for use in treating cancer patients. สล็อตเว็บตรง